128 related articles for article (PubMed ID: 31918397)
1. 4-(4-Chlorophenyl)thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibition.
Smelcerovic A; Zivkovic A; Ilic BS; Kolarevic A; Hofmann B; Steinhilber D; Stark H
Bioorg Chem; 2020 Jan; 95():103528. PubMed ID: 31918397
[TBL] [Abstract][Full Text] [Related]
2. Thiazole derivatives as dual inhibitors of deoxyribonuclease I and 5-lipoxygenase: A promising scaffold for the development of neuroprotective drugs.
Marković A; Živković A; Atanasova M; Doytchinova I; Hofmann B; George S; Kretschmer S; Rödl C; Steinhilber D; Stark H; Šmelcerović A
Chem Biol Interact; 2023 Aug; 381():110542. PubMed ID: 37224992
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazoles as novel deoxyribonuclease I inhibitors.
Kolarević A; Ilić BS; Anastassova N; Mavrova AT; Yancheva D; Kocić G; Šmelcerović A
J Cell Biochem; 2018 Nov; 119(11):8937-8948. PubMed ID: 30054936
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and DNase I inhibitory properties of some 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines.
Ts Mavrova A; Dimov S; Yancheva D; Kolarević A; Ilić BS; Kocić G; Šmelcerović A
Bioorg Chem; 2018 Oct; 80():693-705. PubMed ID: 30064080
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors.
Suh J; Yum EK; Cheon HG; Cho YS
Chem Biol Drug Des; 2012 Jul; 80(1):89-98. PubMed ID: 22404847
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and analysis of 4-oxothiazolidines as potential dual inhibitors of deoxyribonuclease I and xanthine oxidase.
Gajić M; Džambaski Z; Ilić BS; Kocić G; Bondžić BP; Šmelcerović A
Chem Biol Interact; 2021 Aug; 345():109536. PubMed ID: 34058176
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and DNase I inhibitory properties of some 4-thiazolidinone derivatives.
Kolarević A; Ilić BS; Kocić G; Džambaski Z; Šmelcerović A; Bondžić BP
J Cell Biochem; 2019 Jan; 120(1):264-274. PubMed ID: 30171712
[TBL] [Abstract][Full Text] [Related]
8. 1,2,3,4-Tetrahydroisoquinoline Derivatives as a Novel Deoxyribonuclease I Inhibitors.
Gajić M; Ilić BS; Bondžić BP; Džambaski Z; Kojić VV; Jakimov DS; Kocić G; Šmelcerović A
Chem Biodivers; 2021 Aug; 18(8):e2100261. PubMed ID: 34170076
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones.
Bondžić BP; Džambaski Z; Kolarević A; Đorđević A; Anderluh M; Šmelcerović A
Future Med Chem; 2019 Sep; 11(18):2415-2426. PubMed ID: 31526044
[No Abstract] [Full Text] [Related]
10. Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenase.
Peduto A; Scuotto M; Krauth V; Roviezzo F; Rossi A; Temml V; Esposito V; Stuppner H; Schuster D; D'Agostino B; Schiraldi C; de Rosa M; Werz O; Filosa R
Eur J Med Chem; 2017 Feb; 127():715-726. PubMed ID: 27836196
[TBL] [Abstract][Full Text] [Related]
11. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
Hanke T; Dehm F; Liening S; Popella SD; Maczewsky J; Pillong M; Kunze J; Weinigel C; Barz D; Kaiser A; Wurglics M; Lämmerhofer M; Schneider G; Sautebin L; Schubert-Zsilavecz M; Werz O
J Med Chem; 2013 Nov; 56(22):9031-44. PubMed ID: 24171493
[TBL] [Abstract][Full Text] [Related]
12. Deoxyribonuclease I Inhibitory Properties, Molecular Docking and Molecular Dynamics Simulations of 1-(Pyrrolidin-2-yl)propan-2-one Derivatives.
Ilić BS; Gajić M; Bondžić BP; Džambaski Z; Kocić G; Šmelcerović A
Chem Biodivers; 2021 Mar; 18(3):e2000996. PubMed ID: 33529484
[TBL] [Abstract][Full Text] [Related]
13. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX.
Omar YM; Abdu-Allah HHM; Abdel-Moty SG
Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase Inhibitory Activities of N-Phenylthiazol-2-Amine Derivatives and their Molecular Docking Studies.
Iqbal J; al-Rashida M; Babar A; Hameed A; Khan MS; Munawar MA; Khan AF
Med Chem; 2015; 11(5):489-96. PubMed ID: 25537128
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and DNase I Inhibitory Properties of New Squaramides.
Ruseva N; Sbirkova-Dimitrova H; Atanasova M; Marković A; Šmelcerović Ž; Šmelcerović A; Bakalova A; Cherneva E
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677597
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vivo anti-inflammatory, COX-1/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophene derivatives.
Qandeel NA; El-Damasy AK; Sharawy MH; Bayomi SM; El-Gohary NS
Bioorg Chem; 2020 Sep; 102():103890. PubMed ID: 32801081
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]